Global Radiotherapy Market - A $10.20 billion Opportunity, Reveals New Report

The global radiotherapy market is a widely growing sector in recent years and is driven by factors such as increasing number of cancer patients and untapped market in some emerging countries. However factors such as expensive treatments, adequate infrastructure and adequate skills and training are hampering the market growth. The external beam radiation therapy is the largest segment of the Radiotherapy market followed by internal beam radio therapy, the global radiotherapy market is expected to grow at a compound annual growth rate (CAGR) of 6.65% and reach US$10.2 billion by 2022 from $6.1 billion in 2014.

The Global Radiotherapy Market could be segmented by technology and geography. On the basis of technology, it can be categorized to external beam radiation therapy, internal beam radio therapy  and  Systemic Radiation Therapy. By geography, it is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America has the highly competitive and largest market for radiotherapy devices followed by Europe.

The key players in the Global Radiotherapy Market are C.R. BARD Inc., Angiodynamics Inc., Accuray Inc., Nordion Inc., Protom International Inc., Varian Medical Systems Inc., Siemens Healthcare, GE Healthcare, IBA Group and Coviden.

For more information visit: http://www.marketresearchreports.com/stratistics-mrc/global-radiotherapy-market-outlook-2014-2022

To browse more Medical Devices Market Research Reports visit: http://www.marketresearchreports.com/medical-devices